| Older cancer patients | Older persons without cancer |  | ||
---|---|---|---|---|---|
 | N = 134 | N = 220 |  | ||
 | N | % | N | % | pvalue |
Age: mean (SD) | 77.10 | (5.11) | 78.13 | (5.47) | 0.08 |
Gender | Â | Â | Â | Â | 0.001 |
Male | 28 | 21% | 82 | 37% | Â |
Female | 106 | 79% | 138 | 63% | Â |
Living conditions | Â | Â | Â | Â | 0.17 |
Alone | 44 | 33% | 72 | 33% | Â |
With partner | 76 | 57% | 137 | 62% | Â |
With friends/family | 6 | 4% | 7 | 3% | Â |
Institutionalised | 8 | 6% | 4 | 2% | Â |
Cancer site | Â | Â | Â | Â | Â |
Breast | 93 | 69% | Â | Â | Â |
Colorectal | 41 | 31% | Â | Â | Â |
Cancer treatment | Â | Â | Â | Â | Â |
Surgery | 125 | 93% | Â | Â | Â |
Chemotherapy | 39 | 29% | Â | Â | Â |
Radiotherapy | 70 | 52% | Â | Â | Â |
Hormonal therapy | 53 | 40% | Â | Â | Â |
Targeted therapy | 4 | 3% | Â | Â | Â |
Missing | 3 | 2% | Â | Â | Â |
Cancer Stage | Â | Â | Â | Â | Â |
I | 22 | 16% | Â | Â | Â |
II | 72 | 54% | Â | Â | Â |
III | 18 | 13% | Â | Â | Â |
Missing | 22 | 16% | Â | Â | Â |
Geriatric screening tools | Â | Â | Â | Â | Â |
aCGA: Abnormal score | 86 | 64% | 123 | 56% | 0.04 |
 Missing | 12 |  | 12 |  |  |
G8: Abnormal score | 84 | 63% | 119 | 54% | 0.10 |
 Missing | 3 |  | 4 |  |  |
GFI: Abnormal score | 42 | 42% | 98 | 45% | 0.58 |
 Missing | 17 |  | 14 |  |  |
 Not measureda | 35 |  | / |  |  |
VES-13: Abnormal score | 48 | 48% | 109 | 50% | 0.92 |
 Missing | 5 |  | 4 |  |  |
 Not measureda | 35 |  | / |  |  |
Functional impairment b | 97 | 72% | 141 | 65% | 0.12 |
 Missing | 0 |  | 0 |  |  |
 ADL impairment | 69 | 51% | 87 | 41% | 0.06 |
 IADL impairment | 75 | 56% | 113 | 51% | 0.40 |
 Functional decline | 73 | 58% | 93 | 43% | 0.01 |
QoL: mean (SD) a | 69.93 | (19.30) | 75.91 | (17.84) | 0.01 |
 Decline in QoL | 15 | 23% | 50 | 30% | 0.48 |
 Missing | 7 |  | 1 |  |  |
 Not measureda | 35 |  | / |  |  |